TRX-101

N/A

Report date: 2026/01/08 17:58:16
NME

Base Information

Drug NameTRX-101
Drug Alias NameTRX-101
ClassificationSmall molecules
Mechanisms of ActionRho-associated protein kinase 1 inhibitorsRho-associated protein kinase 2 inhibitors
TargetsRho-associated protein kinase 1Rho-associated protein kinase 2
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTheron Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesTheron Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A